We have found that Balb/c SCID mice develop a more rapid and severe form of colitis than do the C57Bl/6 RAG-1/mice. bowel diseases(IBD; Crohn’s disease; ulcerative colitis) are idiopathic chronic inflammatory disorders of the intestine and/or colon, in which patients suffer from rectal bleeding, severe diarrhea, abdominal pain, fever, and weight loss (5,25,26). Histopathological inspection of biopsies obtained from patients with active disease reveals the presence of a large inflammatory cell infiltrate coincident with extensive mucosal and transmural injury including edema, loss of goblet cells, decreased mucous production, crypt cell hyperplasia, erosions, and ulcerations. A major limitation in understanding the pathogenetic mechanisms responsible for the induction and perpetuation of these chronic inflammatory disorders has been the availability of animal models that recapitulate the human diseases. Over the past 15 years a number of different rodent models have been developed that have greatly advanced our understanding of disease pathogenesis. Currently, there are least 2530 different mouse and rat models of intestinal inflammation that may be grouped into three major categories according 4-Aminobutyric acid to the nature of 4-Aminobutyric acid the inflammation and method of the induction of the disease (4). These include the erosive, self-limiting models of colitis; spontaneous models of chronic colonic (and/or small bowel) inflammation induced by targeted gene deletion; and models of chronic colitis and intestinal inflammation induced by disruption of T cell homeostasis. Although no single animal model completely recapitulates the clinical and histopathological characteristics of human IBD, data obtained from a number of different 4-Aminobutyric acid studies using the various rodent models have revealed three basic underlying principles and recurring themes (4,25). First, chronic gut inflammation is largely mediated by T lymphocytes (T cells). Second, commensal enteric bacteria are required to initiate and perpetuate intestinal and/or colonic inflammation. Finally, the genetic background of the animal represents an important modulator/modifier of disease onset and severity. Indeed, data obtained from a number of different experimental studies suggest that chronic gut inflammation results from a dysregulated immune response to components of the normal gut flora. Thus it is reasonable to suggest that T cell-dependent models of IBD are significantly more relevant to human disease than are the erosive, self-limiting models of acute colitis if one wishes to investigate the immunological mechanisms responsible for the induction, perpetuation, and/or regulation of the chronic disease. Of the many spontaneous models of chronic colitis that have been developed, only a small number of these models have been used by sufficient numbers of investigators to yield detailed information on the penetrance, severity, and reproducibility of the gut inflammation. By far the most widely used of the gene-targeted models of spontaneous colitis is the IL-10-deficient (IL-10/) mouse. Mice with targeted disruption (i.e., deletion) of the IL-10 gene develop spontaneous pancolitis and cecal inflammation by 24 mo of age (1). Histopathological Mouse monoclonal to CD19.COC19 reacts with CD19 (B4), a 90 kDa molecule, which is expressed on approximately 5-25% of human peripheral blood lymphocytes. CD19 antigen is present on human B lymphocytes at most sTages of maturation, from the earliest Ig gene rearrangement in pro-B cells to mature cell, as well as malignant B cells, but is lost on maturation to plasma cells. CD19 does not react with T lymphocytes, monocytes and granulocytes. CD19 is a critical signal transduction molecule that regulates B lymphocyte development, activation and differentiation. This clone is cross reactive with non-human primate inspection of colons obtained from mice with active disease show many of the same characteristics as those observed in 4-Aminobutyric acid human IBD. As with virtually all mouse models of chronic colitis, T cells play an important role in disease pathogenesis. In addition, genetic background of the mouse is a major modifier of disease with disease penetrance and severity occurring to a much greater extent in 129SvEv IL-10/than in C57Bl/6 or Balb/c IL-10/animals. The advantages of using the IL-10/model is that it is a well-established Th1-mediated model of transmural colitis, which can be treated with various immunological agents (anti-TNF-, anti-IFN- antibodies), antibiotics, and probiotics. However, onset and severity of disease are variable and in some cases disease requires many months to develop. Furthermore, we have found that continuous brother-sister mating (inbreeding) of these mice (129SvEv IL-10/) to maintain adequate numbers of animals results in a significant reduction in the penetrance and severity of disease over the course of a 2-yr period. Because of these observations, coupled to the desire to more precisely synchronize the onset and severity of disease, the T cell transfer model of chronic colitis has become more widely used over the past 34 years by a number of different investigators from around the world. This is the prototypical and best-characterized model of chronic colitis induced by disruption of T cell homeostasis. Adaptive transfer of CD4+CD45RBhighT cells (naive T cells) from healthy wild-type (WT) mice into syngeneic recipients that lack T and B cells induces a pancolitis and small bowel inflammation at 58 wk following.